These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3856696)

  • 21. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group.
    Nesbit ME; Sather H; Robison LL; Donaldson M; Littman P; Ortega JA; Hammond GD
    Cancer Res; 1982 Feb; 42(2):674-80. PubMed ID: 7034927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia.
    Dow LW; Borella L; Sen L; Aur RJ; George SL; Mauer AM; Simone JV
    Blood; 1977 Oct; 50(4):671-82. PubMed ID: 268981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of the FAB morphologic criteria and prognosis in acute lymphocytic leukemia of childhood.
    Wagner VM; Baehner RL
    Am J Pediatr Hematol Oncol; 1979; 1(2):103-6. PubMed ID: 295577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of mediastinal mass in acute lymphoblastic leukemia.
    Ravindranath Y; Kaplan J; Zuelzer WW
    Pediatrics; 1975 Jun; 55(6):889-93. PubMed ID: 1094403
    [No Abstract]   [Full Text] [Related]  

  • 26. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.
    Boissel N; Auclerc MF; Lhéritier V; Perel Y; Thomas X; Leblanc T; Rousselot P; Cayuela JM; Gabert J; Fegueux N; Piguet C; Huguet-Rigal F; Berthou C; Boiron JM; Pautas C; Michel G; Fière D; Leverger G; Dombret H; Baruchel A
    J Clin Oncol; 2003 Mar; 21(5):774-80. PubMed ID: 12610173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
    Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
    Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates.
    Yanada M; Jinnai I; Takeuchi J; Ueda T; Miyawaki S; Tsuzuki M; Hatta Y; Usui N; Wada H; Morii T; Matsuda M; Kiyoi H; Okada M; Honda S; Miyazaki Y; Ohno R; Naoe T
    Leuk Res; 2007 Jul; 31(7):907-14. PubMed ID: 17005250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of Memphis-study VII ("Pinkel-Therapy") in 659 children with acute lymphoblastic leukemia. Cooperative therapeutic study of the German working group on childhood leukemia with participation of 42 hospitals].
    Lampert F
    Klin Padiatr; 1978 Jan; 190(1):57-64. PubMed ID: 273115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of acute promyelocytic leukemia in Czechia: results and analysis of prognostic factors].
    Schwarz J; Korístek Z; Starý J; Zák P; Kozák T; Marková J; Michalová K; Dvoráková D; Mayer J; Cetkovský P
    Vnitr Lek; 2008; 54(7-8):757-70. PubMed ID: 18780575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
    de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA
    Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
    Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
    J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical characteristics and treatment results of acute promyelocytic leukemia in children (Children's Cancer and Leukemia Study Group)].
    Shimizu H; Nakadate H; Taga T; Utsumi J; Nishikawa K; Gushiken T; Horikoshi Y; Oka T; Kikuta A; Maeda H
    Rinsho Ketsueki; 1993 Sep; 34(9):989-96. PubMed ID: 8230751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An analysis of prognostic factors and the five-year survival rate in childhood acute lymphoblastic leukemia.
    Karimi M; Yarmohammadi H; Sabri MR
    Med Sci Monit; 2002 Dec; 8(12):CR792-6. PubMed ID: 12503037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prophylactic central nervous system irradiation for childhood acute lymphoblastic leukemia].
    Chatani M; Teshima T; Inoue T; Azuma I; Kumano M; Hishikawa Y; Kondo K; Suyama T; Yabumoto E; Nakajima T
    Gan No Rinsho; 1984 Apr; 30(4):363-7. PubMed ID: 6587134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
    Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
    Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
    Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic factors for childhood acute non-mature B-lymphoblastic leukemia].
    Jiang H; Gu LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Xu C; Dong L; Zhou M
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):290-4. PubMed ID: 18554450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials.
    Mandrekar SJ; Schild SE; Hillman SL; Allen KL; Marks RS; Mailliard JA; Krook JE; Maksymiuk AW; Chansky K; Kelly K; Adjei AA; Jett JR
    Cancer; 2006 Aug; 107(4):781-92. PubMed ID: 16847887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of central nervous system involvement at diagnosis of childhood T-cell acute lymphoblastic leukemia.
    Jaing TH; Yang CP; Hung IJ; Tsay PK; Tseng CK; Chen SH
    Pediatr Blood Cancer; 2005 Aug; 45(2):135-8. PubMed ID: 15704218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.